Vemurafenib as first-line therapy in BRAF -V600E-mutant Erdheim-Chester disease with CNS involvement

1. Fernández-Eulate, G.
2. Muñoz-Lopetegi, A.
3. Ruiz, I.
4. Urtasun, M.